# Study of CRx-191 to Assess Activity in Plaque Psoriasis

> **NCT00557739** · PHASE2 · COMPLETED · sponsor: **Zalicus** · enrollment: 20 (estimated)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** mometasone furoate
- **DRUG:** nortriptyline HCl
- **DRUG:** Vehicle (placebo)

## Key facts

- **NCT ID:** NCT00557739
- **Lead sponsor:** Zalicus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2008-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557739, "Study of CRx-191 to Assess Activity in Plaque Psoriasis". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00557739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*